Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

EMERYVILLE, Calif., Aug. 27, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in a fireside chat at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3rd at 4:30 p.m. ET.The presentations will be webcast and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at https: ...